Form 4: Certara CEO Jon Resnick Receives Large Equity Grant
Statement of Changes in Beneficial Ownership
Certara CEO Jon Matthew Resnick was granted significant performance and restricted stock units as part of his employment agreement.
Summary
- CEO Jon Matthew Resnick received a substantial equity package on May 11, 2026, under the company's 2020 Incentive Plan.
- The grant includes 268,949 performance stock units (PSUs) tied to 2025 LTI price thresholds and 740,740 PSUs tied to 2026 LTI price thresholds.
- Additionally, the CEO received three tranches of restricted stock units (RSUs) totaling 1,401,531 units with varying vesting schedules through 2029.
- 59,766 RSUs vested on May 11, 2026, with 24,377 shares withheld for tax obligations.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral administrative filing regarding executive compensation, which is expected for a public company and does not signal immediate operational changes.
Positives
- Equity-based compensation aligns the CEO's long-term incentives with shareholder value creation through performance-based stock price thresholds.
- The multi-year vesting schedule for RSUs encourages long-term retention of executive leadership.
Negatives
- The issuance of over 2.4 million potential shares through PSUs and RSUs represents significant potential dilution for existing shareholders.
Risks
- Achievement of performance-based stock units is contingent upon meeting specific stock price thresholds, which may not be met if market conditions deteriorate.
- The reliance on stock-based compensation may lead to increased volatility in executive compensation expenses.
Future Outlook
The CEO's compensation is heavily weighted toward future performance, with PSUs vesting based on stock price thresholds through 2029 and RSUs vesting in installments through 2029.
Management Comments
- The grants were made pursuant to the terms of Mr. Resnick's employment agreement under the 2020 Incentive Plan.
Industry Context
StockSavvy.ai notes that large equity grants for CEOs in the biotech and software services sector are standard practice to ensure leadership alignment with long-term growth, though the scale of this grant reflects a significant commitment to the current CEO's tenure.
Comparison to Industry Standards
- The use of performance-based stock units (PSUs) with 0% to 200% payout ranges is consistent with current executive compensation benchmarks for mid-cap technology and life sciences firms.
- The multi-year vesting schedule (3-4 years) aligns with standard corporate governance practices for executive retention.
Stakeholder Impact
- Shareholders may experience dilution from the issuance of new shares upon the vesting of these units.
- The alignment of CEO compensation with stock price performance may incentivize management to focus on long-term share price appreciation.
Next Steps
- Monitor future SEC filings for potential vesting events.
- Track company stock price performance against the thresholds defined for the 2025 and 2026 LTI plans.
Key Dates
| Date | Description |
|---|---|
| 05/11/2026 | Date of grant for RSUs and PSUs and vesting of initial RSU tranche. |
| 05/13/2026 | Date of filing for the Form 4. |
| 01/01/2027 | First vesting date for RSU tranche (6). |
| 04/01/2027 | Vesting date for RSU tranches (1) and (5). |
| 01/01/2028 | Final vesting date for RSU tranche (6). |
| 04/01/2028 | Final vesting date for RSU tranches (1) and (5) and deadline for 2025 LTI performance period. |
| 03/31/2029 | Deadline for 2026 LTI performance period. |
| 04/01/2029 | Final vesting date for RSU tranche (5). |
Keywords
Certara, CERT, CEO, Equity Compensation, Insider Trading, Form 4, Stock Options, Executive Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.